Lindberg_1998_Int.J.Mol.Med_1_529

Reference

Title : A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes - Lindberg_1998_Int.J.Mol.Med_1_529
Author(s) : Lindberg A , Nordstoga K , Christophersen B , Savonen R , van Tol A , Olivecrona G
Ref : Int J Mol Med , 1 :529 , 1998
Abstract :

Severe hypertriglyceridemia was previously observed in mink. Affected animals had no detectable lipoprotein lipase activity, but normal amounts of lipoprotein lipase protein in post-heparin plasma. We have now cloned cDNA for lipoprotein lipase from normal mink and identified a single point mutation in the affected animals which most likely explains the deficiency of active lipase. The mutation is located in exon 6 and results in a Pro214Leu substitution. In heterozygote mink the levels of lipoprotein lipase activity and mass in post-heparin plasma were lower than in normal mink, but could not be used to identify carriers of the mutation. In some tissues (heart, muscle, kidney and lung), lipoprotein lipase activity was decreased to about 50%. In adipose tissue there seemed to be a mechanism to compensate for the mutation, resulting in increased mass and approximately the same activity of lipoprotein lipase as in animals not carrying the mutation. Mink had high lipoprotein lipase activity and mass in kidneys, although the levels of mRNA in kidney were many fold lower than in adipose tissue. Mink had very low levels of cholesteryl ester transfer protein activity in plasma. This may contribute to the high levels of HDL in this animal species.

PubMedSearch : Lindberg_1998_Int.J.Mol.Med_1_529
PubMedID: 9852258
Gene_locus related to this paper: musvi-lipli

Related information

Gene_locus musvi-lipli

Citations formats

Lindberg A, Nordstoga K, Christophersen B, Savonen R, van Tol A, Olivecrona G (1998)
A mutation in the lipoprotein lipase gene associated with hyperlipoproteinemia type I in mink: studies on lipid and lipase levels in heterozygotes
Int J Mol Med 1 :529

Lindberg A, Nordstoga K, Christophersen B, Savonen R, van Tol A, Olivecrona G (1998)
Int J Mol Med 1 :529